Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Our approach includes a targeted mix of hormonal treatments, carefully chosen nutraceuticals, and personalized nutritional guidance derived from individual lab tests. We aim to reactivate genes that have become inactive as a result of aging. Our studies indicate that this method can not only stabilize but potentially enhance vision in nearly half of the participants suffering from macular degeneration. Additionally, it could decrease the frequency of eye injections and reduce the chances of the condition worsening from the dry type to the more severe wet type.
We highly advocate for patients to undertake this program, which is grounded in scientific research, as soon as possible. Early participation can significantly diminish the likelihood of the disease advancing to an irreversible stage.
Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Difficulty seeing in dim light.
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory.
Difficulty seeing in dim light..
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory
The HOMING Method guides the personalized care plan for Age-related Macular Degeneration (AMD).
HOMING is an acronym for Hormones, Oxidation, Methylation, Inflammation, Nutrition and Genetics. The goal is to improve cell biochemistry either directly or by epigenetic mechanisms, (reawakening dormant genes that down regulate with aging)
Literature Citation demonstrating stability and improvement of dry and wet AMD
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
48% of dry AMD improved.
60% of wet AMD improved.
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
The HOMING method has been a success in many clinical conditions indicating that addresses root causes of disease.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Board Certified Ophthalmology
Ph.D. in Biochemistry
Board Certified Ophthalmologist / Biomedical Engineer
PhD in Biochemistry
When Bob, a passionate skeet and trap shooting coach, reached out to Dr. Rozakis and the team at the Macular Program, his words weren't just a letter; they were a testament to hope, resilience, and the human spirit's indomitable will to reclaim life from the clutches of wet macular degeneration.
"Dr. Rozakis, I am enrolled in your Macular Program. I am seeing some definite improvement in my eye with wet macular degeneration." These opening lines from Bob's letter resonate with the silent battles fought by many facing the challenges of macular degeneration, a condition that doesn't just blur vision but also the joys and colors of life.
Bob's journey with the Macular Program has seen him move from a visual acuity of 20/80 to an astonishing 20/50 or even 20/40, depending on his tech usage. For someone whose world was dimming, this improvement is nothing short of a leap towards light. "It seems to alternate back-and-forth and is better at 20/40 when I used my cell phone sparingly," he writes, highlighting how even small lifestyle adjustments can amplify the benefits of the Macular Program's comprehensive care plan.
But what truly captures the essence of Bob's story is his return to skeet and trap shooting, not with the perfection he once knew, but with a spirit of fun and fulfillment. "I am gradually getting able to shoot, a skeet and trap again. Not perfectly but having fun (I am also a coach and both)." These words aren't just about regaining the ability to engage in a cherished hobby; they're about reclaiming identity, passion, and the simple joys that define living.
Bob's narrative is a powerful beacon for anyone navigating the uncertain waters of wet macular degeneration. It's raw, relatable, and profoundly human, illustrating that the journey through treatment is not just about medical outcomes but about rekindling the spark of life that conditions like AMD threaten to extinguish.
The Macular Program, with its pioneering approach combining treatment shots and tailored supplements, stands at the forefront of this battle, offering not just hope but tangible results. Dr. Rozakis and his team aren't just treating a condition; they're restoring lives, one patient at a time.
Bob's story, woven with threads of improvement, passion, and resilience, serves as a compelling invitation to those struggling in the dark. It's a message that you're not alone, that improvement isn't just a possibility but a reality for many. It underscores the power of personalized care, the importance of embracing every small victory, and the joy of rediscovering life's passions.
In essence, Bob's letter is more than just words on paper. It's a testament to the transformative power of hope, the importance of personalized care, and the profound impact of the Macular Program. It's a reminder to us all that in the face of adversity, with the right support, we can find our way back to the things we love, not perfectly, but with joy and gratitude for the journey.
As we draw inspiration from Bob's heartfelt journey, it's clear that the fight against macular degeneration is not just a dream—it's a reality for those who dare to hope and act. If Bob's story has ignited a spark within you, or if you or someone you know is navigating the challenging waters of macular degeneration, we invite you to dig deeper. Join the Macular Masterclass, a beacon of knowledge and empowerment for those seeking to reclaim their vision and vitality.
Our study followed patients for 6 months. Those who improved did so generally between 2 and 6 months. Unpublished data is showing that these effects are not lost out to 2-3 years and additional improvement is possible with more time. Time and compliance with the program are the keys to continued success.
Similar to exercise and dietary practices, the favorable changes in your blood chemistry can only be sustained as long as you are taking your program.
Yes. Consistently adhering to our program has led to marked improvements for our patients. It is the combination of time and unwavering commitment to the program that paves the way for enduring success.
This decision is made by you retina doctor. However it is reasonable to ask to decrease the time between injection if the OCT scans show no remaining fluid because the HOMING Method, according to scientific literature, may decrease the creation of growth factors in the eye (for which you are receiving the injections).
The Macular Program is a form of anti-aging medicine since macular degeneration is actually called AGE RELATED macular degeneration. Fighting aging is fighting AMD. What is nice is that treating AMD with HOMING also benefits other aging symptoms which is why we want to know about your eye AND General Health.
Age-Related Macular Degeneration (AMD), whether dry or wet, is a complex condition influenced by numerous factors. Our HOMING method helps to prevent, stabilize and even reverse macular degeneration.
Geographic Atrophy is a special form of dry macular degeneration that is felt to be caused by inflammation. The HOMING method reduces inflammation. Our clinical suspicion is that GA does not worsen if a patient is on the HOMING Method. This is an important matter because new drugs now exist to fight inflammation in eyes with GA, but these drugs need to be injected into the eye. We hope the HOMING method will allow patients to avoid eye injections for GA. The smart move is to be on the HOMING method and have the GA closely followed for progression. If no progression, then you don’t need shots. It’s your call.
MacularProgram© 2023 | All Rights Reserved
All Rights Reserved 2024
Macular Program
Contact Us:
440-777-2667
Email Us: info@macularprogram.com